𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P-230 A phase II study of weekly docetaxel plus capecitabine for patients with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Han, Ji-Youn; Lee, Dae Ho; Kim, Hae Young; Chun, Jong Ho; Yoon, Sung Min; Lee, Hong Gi; Lee, Sung Young; Shin, Eun Hee; Yoo, Han Jin; Lee, Jin Soo


Book ID
118571931
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
187 KB
Volume
41
Category
Article
ISSN
0169-5002

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


A phase II study of weekly docetaxel plu
✍ Ji-Youn Han; Dae Ho Lee; Hae Young Kim; Eun Kyung Hong; Sung Min Yoon; Jong Ho C πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Docetaxel is an active agent in advanced nonsmall‐cell lung carcinoma (NSCLC) and demonstrates preclinical and clinical synergism with capecitabine. We conducted the current Phase II study to evaluate the efficacy and safety of the docetaxel/capecitabine combination in ch